American Journal of Ophthalmology
Volume 145, Issue 2 , Pages 239-248.e5, February 2008

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

  • Carl D. Regillo

      Affiliations

    • Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania
    • Corresponding Author InformationInquiries to Carl D. Regillo, Wills Eye Institute, 840 Walnut Street, Suite 1020, Philadelphia, PA 19107
    • ,
  • David M. Brown

      Affiliations

    • Vitreoretinal Consultants, The Methodist Hospital, Houston, Texas
    • ,
  • Prema Abraham

      Affiliations

    • BH Regional Eye Institute, Rapid City, South Dakota
    • ,
  • Huibin Yue

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • Tsontcho Ianchulev

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • Susan Schneider

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • Naveed Shams

      Affiliations

    • Genentech, Inc, South San Francisco, California.
    • ,
  • The PIER Study Group

Accepted 5 October 2007. published online 03 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supplemental Material available at AJO.com.

PII: S0002-9394(07)00881-1

doi:10.1016/j.ajo.2007.10.004

American Journal of Ophthalmology
Volume 145, Issue 2 , Pages 239-248.e5, February 2008

Article Tools

* Image Usage & Resolution